National HealthCare Corporation research snapshot

NHC AI Stock Analysis

NHC AI stock analysis reads National HealthCare Corporation as a 55-year operator of skilled nursing, assisted living, independent living, home care, and hospice services across the southeastern United States. At the August 4, 2026 data cutoff, NHC traded near $223.39 with a verified market capitalization of approximately $3.50 billion, having completed the purchase of 32 skilled nursing and 3 independent living facility properties from National Health Investors (NHI) for $560 million on July 1, 2026. This page presents scenario ranges, technical levels, and source-verified data, not a certain stock price prediction, and is for informational use only.

Current price

$223.39

Market cap

Approximately $3.50 billion

AI score

62 / 100

Rating

Quality senior care operator trading at a full valuation after a transformative acquisition

Trend status

Near 52-week high after completing the $560M NHI facility purchase

Data cutoff (updated monthly)

August 4, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness
B-level information richness. NHC is a NYSE American company with 55 years of operating history, SEC filings, quarterly earnings, and analyst coverage from Argus Research (BUY rating). However, the $560M NHI portfolio acquisition closed only in July 2026, so combined-entity financials are not yet visible and near-term projections carry more uncertainty than for a steady-state operator.
bias Check
The main AI bias risk is over-weighting the strong recent stock performance (up roughly 135% over 52 weeks) and the acquisition momentum while under-weighting integration execution, skilled nursing labor costs, and an elevated 28.7x TTM P/E relative to the companys historical 15-18x range. The reverse check asks whether the expanded portfolio can generate returns above cost of capital and whether the market is already pricing in a smooth integration.
ai Confidence
High for share count, market cap, revenue, net income, and FCF, which were cross-validated across Yahoo Finance, Google Finance, and StockAnalysis. Medium for forward earnings estimates and integration scenarios because the NHI portfolio acquisition closed in July 2026 and combined financials are not yet reported.
investment Certainty
Medium. NHC is understandable as a senior care operator with real estate assets, net cash, and recurring revenue from government and private-pay sources. Investment certainty is moderate because the acquisition, while strategically logical, introduces integration and operational scale risks, and the stock now trades above its historical average multiple.

Quick verdict table

DimensionConclusionConfidence
Business qualityNHC operates 80 skilled nursing facilities with 10,323 beds, 26 assisted living communities with 1,413 units, 9 independent living communities, 3 behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies across 11 states. Revenue is recurring and partly protected by aging demographics, with TTM revenue of about $1.53 billion and TTM net income of $123.67 million.Medium-high
MoatMoat is moderate and locally grounded in licensed bed capacity, real estate ownership, hospital referral relationships, and 55 years of operating history in the southeastern US. The completed NHI purchase converts leased properties into owned assets, deepening the asset-backed position, but the industry is fragmented and Ensign (ENSG) has greater scale.Medium
ManagementManagement under CEO Stephen Fowler Flatt completed a $560M purchase of 35 NHI properties in July 2026 and a separate $50.5M five-facility transaction, converting leases into ownership. Insider ownership near 12.4% aligns incentives. The key test is whether integration is accretive and debt stays controlled.Medium
Financial trendRevenue has grown from about $1.07 billion in 2021 to $1.53 billion TTM, with TTM growth of about 11%. NHC holds $258.35 million cash against $39.31 million total debt for net cash of about $219 million, and generated $168.41 million TTM free cash flow. The balance sheet is conservative with debt to equity near 4%.High
ValuationAt $223.39, NHC trades near 28.7x TTM P/E, 3.2x book value, and 2.3x sales, above the 5-year average and its FY2025 multiple of about 17.9x. EV/EBITDA is roughly 18.8x on TTM EBITDA of $175.39 million. The scenario model suggests the price embeds base-to-bullish expectations for the acquisition.Medium
Technical trendNHC is in a strong uptrend from a 52-week low near $94 to about $223, near the 52-week high of $232-$233. The 50-day moving average near $206 sits above the 200-day near $164, with RSI around 56, indicating momentum without an overbought extreme.Medium
Risk levelMain risks are NHI portfolio integration execution, skilled nursing labor shortages and wage inflation, Medicaid/Medicare reimbursement rate changes, regulatory compliance, and a valuation that leaves limited room for disappointment after a roughly 135% 52-week rally.Medium-high
AI confidenceHigh for descriptive and cross-validated facts such as price, market cap, revenue, net income, and FCF. Medium for forward integration scenarios and combined financial estimates because the NHI acquisition closed only in July 2026.Medium-high data confidence
Investment certaintyMedium certainty. The page frames scenarios and monitoring rules, not a buy or sell instruction. The acquisition is transformative and its success will determine whether the current above-average multiple is justified.Medium

NHC AI stock forecast

NHC AI Stock Forecast Scenarios

The NHC AI stock forecast uses scenario math around the $223.39 quote and current earnings power of $7.87 TTM EPS. A three-year framework produced a bearish area near $125, a base area near $206, and a bullish area near $272 if the stated growth and valuation assumptions hold.

Bullish case

$255 to $285

More likely if the NHI portfolio integration is smooth and accretive, occupancy continues recovering, labor cost pressures ease, and the market sustains a 24-26x multiple on normalized EPS above $10.00.

Base case

$190 to $215

More likely if NHC maintains mid-single-digit EPS growth of 5-7%, the NHI acquisition is modestly accretive, occupancy stabilizes, and the stock trades near 20-22x forward earnings.

Bearish case

$115 to $140

More likely if the NHI acquisition faces integration difficulties, skilled nursing labor costs escalate, Medicaid/Medicare reimbursement rates are cut, or a recession reduces occupancy and private-pay volumes.

NHC AI technical analysis

NHC AI Technical Analysis

NHC AI technical analysis shows a strong upward trend from the 52-week low near $94, with the stock trading around $223 and just below the 52-week high near $232-$233 as of the August 4, 2026 data cutoff. RSI near 56 and a rising 50-day moving average near $206 support the trend, but volume should be watched for confirmation near resistance.

LevelValueWhy it matters
Current price$223.39Google Finance quote on August 3, 2026. Yahoo Finance showed a July 27 close of $226.09 and StockAnalysis showed $222.26 on August 3.
Near support$206 areaThe 50-day moving average near $206 (StockAnalysis, August 3, 2026) is the first support and a common reference for trend followers.
Deeper support$195 to $200The $195 to $200 zone reflects the earlier consolidation area after the 2026 rally and offers a secondary level to watch if the 50-day fails.
Main resistance$232 to $233The 52-week high near $232-$233 is the main overhead resistance. Yahoo shows the high near $232.25 and Google near $232.67.
Breakout target$245 to $260If NHC clears the 52-week high on volume, the next technical target zone would be around $245 to $260 based on prior range extension patterns.
MomentumRSI near 56StockAnalysis reported an RSI of 55.89 on August 3, 2026, positive momentum without an overbought extreme after the sustained rally.
VolumeAverage volume near 104K to 144K sharesYahoo Finance shows average volume of 127,721 shares, Google 143,640, and StockAnalysis 104,527 over 20 days. A small float of 12.65M shares means moves can amplify.
VolatilityBeta near 0.64Both Yahoo and Google report a 5-year beta near 0.64, below market average, and the company holds net cash, reducing financial volatility.
InvalidationClose below $206, then $195 to $200A decisive close below the 50-day near $206 would weaken the trend. A close below the $195-$200 zone would suggest a return to the lower end of the multi-month range.

NHC AI trading strategy

NHC AI Trading Strategy Framework

The NHC AI trading strategy is a rules-based research framework for monitoring a senior care operator after a transformative portfolio expansion. It is not personal advice and should be paired with fresh filings, price data, position sizing, and risk limits.

Trend-following setup

Watch for NHC to clear the $232-$233 resistance zone on above-average volume and hold above it. A sustained move toward the $245-$260 area would require continued integration progress on the NHI facilities, stable occupancy, and steady reimbursement trends.

A close back below the 50-day near $206 or a failed breakout after the next earnings update should invalidate the near-term trend-following setup.

Mean-reversion setup

If NHC pulls back toward the $206 area or the $195-$200 support zone without a negative fundamental catalyst, compare the pullback with occupancy data, labor cost trends, and management guidance before assuming support is durable.

Do not average down without a maximum loss rule because healthcare services stocks can gap on reimbursement, regulatory, or labor market news.

Fundamental monitor

Track NHI integration progress and margin contribution, skilled nursing occupancy, labor cost per patient day, Medicaid/Medicare reimbursement changes, free cash flow conversion, balance sheet leverage after the acquisition financing, and insider trading patterns.

Reduce confidence if NHI integration shows cost overruns, occupancy declines, FCF conversion deteriorates, insider selling accelerates, or debt rises materially from acquisition financing.

Investment research summary

Four-master Research Compression

Business essence

NHC operates skilled nursing, assisted living, independent living, home care, and hospice services primarily in the southeastern United States. Customers, patients and their families, pay for long-term and post-acute care funded by Medicare, Medicaid, private insurance, and private-pay sources.

Moat

The moat is moderate and locally grounded. NHCs 55-year operating history, licensed bed capacity, owned real estate, and relationships with hospital discharge planners create local competitive positions. The $560M NHI purchase converts leased properties into ownership, but the senior care industry stays fragmented and Ensign (ENSG) competes at larger scale.

Munger risk inversion

The thesis fails if NHI integration proves slower or more expensive than expected, the expanded portfolio cannot hold historical occupancy and margin levels, labor shortages push wage inflation above reimbursement growth, or Medicare/Medicaid policy changes cut reimbursement rates materially.

Management

CEO Stephen Fowler Flatt leads a management team that has run NHC for over five decades. The $560M purchase of 35 NHI properties and a $50.5M five-facility deal mark a decisive shift from leasing to owning. Capital allocation should be judged by whether integration is accretive and returns on invested capital improve.

Industry trend

NHC operates in the senior care industry, which benefits from a long-term demographic tailwind as the US population ages and demand for skilled nursing, assisted living, and home care grows. Labor shortages and reimbursement pressure remain structural challenges to margin expansion.

Valuation and margin of safety

At roughly 28.7x TTM P/E, 3.2x book value, and 18.8x EV/EBITDA, NHC trades above its historical average multiple. The three-scenario model suggests the current price embeds base-to-bullish assumptions about the NHI acquisition and operating environment. Margin of safety would improve if the price revisited the $195-$215 zone while the fundamental thesis stays intact.

Source-backed data

NHC Data Table

Every metric below includes a source and last verification date.

MetricValueSourceLast verified
NHC price$223.39 (Google Finance August 3, 2026); Yahoo July 27 close $226.09Google Finance quoteAugust 4, 2026
Market capitalizationApproximately $3.50 billion, verified as $223.39 x 15.62 million shares (0.30% deviation)financial_rigor.py market cap verificationAugust 4, 2026
TTM revenueApproximately $1,526 million, cross-validated across Yahoo ($1.53B), StockAnalysis ($1,526M), and Google quarterly sum ($1,525.9M)Yahoo Finance and StockAnalysisAugust 4, 2026
TTM net incomeApproximately $123.67 million, cross-validated across Yahoo, StockAnalysis, and Google quarterly sumYahoo Finance key statisticsAugust 4, 2026
Cash and debt$258.35 million cash, $39.31 million total debt, net cash about $219 million; debt/equity near 4%StockAnalysis statisticsAugust 4, 2026
TTM free cash flow$168.41 million, with operating cash flow of $208.36 million and capex of about $40 millionStockAnalysis statisticsAugust 4, 2026
Recent quarterly revenueQ1 2026: $381.82M, Q4 2025: $386.51M, Q3 2025: $382.66M, Q2 2025: $374.91MGoogle Finance quarterly financialsAugust 4, 2026
Recent quarterly net incomeQ1 2026: $35.86M, Q4 2025: $24.85M, Q3 2025: $39.24M, Q2 2025: $23.72MGoogle Finance quarterly financialsAugust 4, 2026
52-week range$94.04 to $232.67Yahoo Finance and Google Finance quote dataAugust 4, 2026
Analyst ratingBUY (Argus Research), price target raised to $245 in late July 2026; prior targets $233, $238, and $232 in July 2026Yahoo Finance research reportsAugust 4, 2026
Shares outstanding15.62 million; insider ownership 12.38%, institutional ownership 68.52%, short interest 4.57% of shares outstandingStockAnalysis statisticsAugust 4, 2026
Dividend$2.68 annual (about 1.2% yield), quarterly $0.67, ex-dividend June 30, 2026; 12 years of dividend growthStockAnalysis dividend dataAugust 4, 2026
NHI facility acquisitionCompleted purchase of 32 skilled nursing and 3 independent living facility properties from National Health Investors for $560 million on July 1, 2026Business Wire via Yahoo Finance newsAugust 4, 2026

Frequently Asked Questions

This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell NHC stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Always verify current filings, prices, risks, and personal suitability before making financial decisions.